Tag: cost of insulin

LETTER: Phillips advocates for lower insulin costs, Paulsen is lobbying for big pharma

To the editor:

Oh, how times have changed. Reading about how Rep. Dean Phillips has been advocating for lowering insulin costs in Congress with H.R. 4010, has me both excited and astounded.

A year ago, with Erik Paulsen we would have never seen our District Three representative working for such an important bill. In fact, Paulsen is now lobbying for big pharma. The ones who are trying their hardest to make life saving medicine inaccessible to people who do not have the means to pay the ridiculously high prices. But, Rep. Phillips is acknowledging how high insulin prices are and the inaccessibility with working on The Emergency Access to Insulin Act (H.R. 4010).

The bill will not only help people get emergency supplies now, but also plan for the future with how to continue having access to insulin.

We have long needed a solution to this crisis and with a person like Phillips in office we are finally seeing one start to arise.

Madeline Pukite, Minnetonka
August 13, 2019

Reps. Angie Craig, Dean Phillips Lead Effort To Lower Insulin Costs

Bill would provide emergency insulin and lower costs for Minnesotans

WASHINGTON, DC – Today, U.S. Reps. Angie Craig (MN-02) and Dean Phillips (MN-03) introduced H.R. 4010, The Emergency Access to Insulin Act. This bill would increase insulin access for underinsured and uninsured patients, make insulin more affordable, and hold big drug companies accountable for jacking up insulin prices and making other life-saving drugs unaffordable for Minnesota families.

The price of insulin has increased by over 600% in recent years, leading Minnesotans to risk their lives by rationing their supplies. This bill, which is the House companion to U.S. Sen. Tina Smith’s Senate bill, would:

  • Provide states with federal grants to set up short-term emergency insulin supplies for uninsured and underinsured patients
  • Help patients find long-term affordable insulin options
  • Penalize big pharmaceutical companies for excessive price increases

“This is not an issue we have the luxury of waiting on. Minnesotans are dying because of the outrageous cost of insulin and other life-saving prescription drugs,” said Rep. Craig. “This bill provides real, immediate solutions to the skyrocketing cost of insulin, while also looking toward long-term fixes by holding big pharmaceutical companies accountable for their bad faith efforts to profit off the backs of working families. I’m proud to partner with my fellow Minnesotans on this critical effort.”

“Over the past two decades, Minnesotans have suffered from a 600% increase in insulin prices,”said Rep. Phillips. “That’s outrageous. Families should not be held hostage by big pharma’s predatory pricing practices. I’m proud to lead this bill with Congresswoman Craig and continue the fight for affordable and accessible health care. We owe it to everyone in our community who relies on this life-saving drug.”

Industry fees could be used to offset some insulin costs

Minnesota State Capitol

Insulin producers could be asked to help fund access to the life-saving drug.

“According to some studies, one in four diabetics are rationing their insulin because they cannot afford it,” said Rep. Michael Howard (DFL-Richfield).

He sponsorsHF485 that would establish an insulin manufacturer’s registration fee to fund an insulin assistance program. That program would serve people who earn too much money to qualify for existing public programs, but not enough to afford the cost of insulin on their own.

View the complete March 5 article by Erin Martin on the Minnesota House of Representatives website here.